Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Provided By GlobeNewswire
Last update: May 18, 2025
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients
with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions
HEOR Analyses of Real-World Data Reveal Disparities in Outcomes
In Females and Older Patients with Non-Obstructive HCM
